Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2026-03-12 @ 5:54 PM
Study NCT ID:
NCT04103905
Status:
COMPLETED
Last Update Posted:
2025-05-18
First Post:
2019-09-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of MIL62 in Treatment of CD20 Positive B-cell Lymphomas
Sponsor:
Beijing Mabworks Biotech Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MIL62-CT01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None